No, not on a standard drug test. The 5-panel, 10-panel, and even most 20-panel urine cups used for workplace, pre-employment, and general screening do not include LSD. That surprises a lot of people, because LSD is a well-known illegal drug with a long history of enforcement. The reason has nothing to do with how dangerous or illegal it is and everything to do with how little of it a person actually takes, how fast the body clears it, and how drug test panels are built in the first place.
LSD can be detected, but only when someone orders a test built specifically to look for it. That distinction matters for probation officers, treatment programs, forensic labs, and clinicians who need to know whether a standard cup or dip card covers hallucinogens at all. It usually does not.
Why LSD is left off standard panels
Every drug on a typical immunoassay panel, THC, cocaine, opiates, amphetamines, PCP, benzodiazepines, is active at doses measured in milligrams. LSD is active at doses measured in micrograms, a difference of roughly a thousand-fold. Clinical dosing studies have given healthy volunteers oral LSD in amounts as small as 5 to 20 micrograms and still measured detectable plasma concentrations, while a typical recreational dose used in pharmacokinetic research is around 100 to 200 micrograms, still a fraction of a single grain of salt in weight.
That tiny dose gets metabolized quickly. In a controlled pharmacokinetic study where healthy subjects received 200 micrograms of oral LSD, researchers measured a terminal elimination half-life of about 8.9 hours and found that only around 1 percent of the dose was recovered as unchanged LSD in urine within 24 hours. Most of the compound is converted into metabolites, mainly 2-oxo-3-hydroxy-LSD, before the body ever excretes it. That same study found roughly 13 percent of the dose showed up in urine as the 2-oxo-3-hydroxy-LSD metabolite, at concentrations several times higher than the parent drug and rising over the course of the day.
Put those two facts together, a microgram-level dose and rapid, near-total metabolism, and there simply is not enough parent compound circulating at concentrations that a low-cost immunoassay strip is built to catch. Immunoassay cups and cassettes are engineered around the cutoff concentrations of the drugs employers and treatment programs test most often. Standard urine panels are built to detect opiates, amphetamines, benzodiazepines, barbiturates, cocaine, PCP, and THC using that immunoassay method, and LSD is not part of that lineup on any commercially standard cup.
What standard panels actually test for
The table below shows what is typically covered on the panel sizes most labs and employers use. None of them include LSD by default, regardless of how many panels are on the cup.
| Panel | What it typically covers | Tests for LSD |
|---|---|---|
| Federal 5-panel (SAMHSA authorized) | Marijuana, cocaine, opiates, PCP, amphetamines | No |
| Standard 10-panel | Adds benzodiazepines, barbiturates, methadone, propoxyphene, MDMA | No |
| 12 to 14-panel | Adds oxycodone, buprenorphine, and similar opioid analogs | No |
| DOT-regulated panel | Marijuana, cocaine, opiates, PCP, amphetamines, plus fentanyl as of the 2025 update | No |
| 20-panel screening cup | Broad opioid, stimulant, and sedative coverage | No |
| Specialty LSD or hallucinogen order | LSD and its 2-oxo-3-hydroxy-LSD metabolite, confirmed by LC-MS/MS | Yes, when specifically ordered |
Federal workplace testing rules illustrate the point well. The Mandatory Guidelines for Federal Workplace Drug Testing Programs define exactly which substances federal agencies are authorized to screen for, and even the most recent update to that authorized panel, which added fentanyl, did not add LSD or any other hallucinogen. A drug test panel only tests for what it was designed and validated to test for, and hallucinogens have never been part of that standard design.
How labs actually test for LSD when it is ordered
There is no cheap, instant-read cup for LSD the way there is for THC or cocaine. When a program actually needs to check for LSD, the sample goes to a laboratory for liquid chromatography-tandem mass spectrometry, LC-MS/MS, which can quantify LSD down to extremely low concentrations and distinguish it from related compounds. Because the parent drug clears so quickly and in such small amounts, labs typically test for both LSD itself and its main urinary metabolite, 2-oxo-3-hydroxy-LSD, since the metabolite is present at higher concentrations and persists a bit longer than the parent compound. This dual-target approach is standard in forensic toxicology literature on LSD detection.
This is a send-out lab test, not a point-of-collection screen. It has to be ordered specifically, usually because there is a clinical, forensic, or legal reason to suspect hallucinogen use, and results are not turned around in minutes the way an immunoassay cup is.
How short is the detection window
Short, even by drug testing standards. Using the pharmacokinetic data above as a guide, roughly half of the urinary LSD recovered in the 200-microgram dosing study appeared within the first 8 hours, and with a terminal half-life under 9 hours, the drug and its metabolite fall below detectable concentrations within a few half-lives. In practical terms, that puts the reliable urine detection window for LSD and its metabolite at somewhere in the range of one to three days after a single dose, even with a sensitive LC-MS/MS method, and considerably less if only the parent drug is targeted. Compare that to THC, which can be detected for days to weeks depending on use pattern, and it becomes clear why a narrow window plus a narrow panel means most LSD use never shows up in routine testing at all.
Who actually tests for LSD
Because it takes a dedicated lab order, LSD testing shows up mainly in a few specific settings.
- Probation and court-ordered testing. When a hallucinogen violation is part of the conditions of release or a treatment mandate, the supervising agency can order a specific LSD panel rather than relying on the standard cup.
- Forensic toxicology. Death investigations, DUI cases involving impairment with no obvious cause on a standard panel, and other medico-legal work routinely use LC-MS/MS methods capable of picking up LSD and its metabolite.
- Clinical settings. Emergency departments evaluating a patient with hallucinogen-consistent symptoms, or addiction treatment programs with a documented reason to suspect hallucinogen use, may order it as a targeted add-on.
Outside of those situations, pre-employment, random workplace, and most school or general clinical screening never touch LSD, because the panels those programs use were never designed to. SAMHSA, which oversees federal drug-free workplace guidance, publishes program requirements built around that same standard panel, not an expanded hallucinogen screen.
Why hallucinogen use often gets missed
Put the pieces together and it is easy to see why hallucinogen use is one of the most commonly missed categories in routine drug testing. The dose is small, the drug is metabolized quickly, the standard immunoassay panels were never built to catch it, and the specialized lab test that can catch it has to be requested on purpose. A program relying only on a standard 5, 10, or 20-panel cup will not detect LSD even with repeat use, because the gap is not a sensitivity problem, it is a design decision about which drugs the panel targets. This is one reason background information on hallucinogens, including how compounds like psilocybin, LSD, and related substances affect the body, is worth understanding separately from what a standard cup can actually confirm. For programs that already deal with a similar hallucinogen detection gap, our article on psilocybin and drug testing covers the same dynamic with magic mushrooms.
Programs that need broader coverage, or that need to understand how detection windows differ across drug classes, should start by confirming what their current panel actually screens for rather than assuming a higher panel count means broader hallucinogen coverage. A closer look at how detection periods vary by drug and specimen type is a useful next step, and our full line of drug test cups, cards, and panels shows what standard programs actually cover so there are no surprises about what is and is not included.
Frequently asked questions
Will a 10-panel or 12-panel drug test detect LSD?
No. Adding more drug categories to a panel does not add LSD unless the panel is specifically built for hallucinogens, which standard 10 and 12-panel cups are not. Those panels expand coverage for opioids, benzodiazepines, and similar drug classes, not hallucinogens.
How long does LSD stay in urine?
Based on published pharmacokinetic data, LSD and its main metabolite, 2-oxo-3-hydroxy-LSD, generally fall below detectable levels within one to three days after a single dose, even using a sensitive lab method. The parent drug alone clears faster than that, since most of a dose is metabolized within the first day.
What kind of test actually detects LSD?
A laboratory-based LC-MS/MS test that specifically targets LSD and its 2-oxo-3-hydroxy-LSD metabolite. There is no rapid, instant-read cup or cassette for LSD comparable to what is used for THC or cocaine.
Why isn't LSD on standard employment drug tests?
The federal panels that most employer drug testing programs are modeled on were built around a small set of commonly abused drugs at milligram-level doses. LSD is active at microgram doses and clears too quickly and in too small a quantity for the immunoassay method those panels use, so it was never included.
Can hair testing pick up LSD?
Hair testing for LSD is technically possible in a forensic lab setting using the same type of mass spectrometry methods used for urine, but it is not a standard offering on commercial hair panels and is far less commonly used than urine-based LC-MS/MS testing for this particular drug.
Related reading
This article is general information, not medical or legal advice. Detection windows vary by individual metabolism, dose, and testing method, and any program with a specific need to screen for LSD or other hallucinogens should confirm panel coverage directly with its testing laboratory.
